Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

VDR gene variations may affect carbohydrate metabolism in young women with hyperandrogenism.

A genetic mutation in the CDH3 gene causes hair loss and vision problems in a young Saudi girl.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Hair steroid measurement is an effective method to diagnose and monitor CAH in developing countries.

Idiopathic hirsutism might not be truly idiopathic but could be an early stage of hyperandrogenic disorders.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

The research helps understand how finasteride works and aids drug development.

Male cells need DHT to respond to testosterone, while female cells do not.

A girl with rickets and hair loss was found to have a rare condition where her body didn't respond to vitamin D treatment.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

Removing part of the vitamin D receptor stops vitamin D from working properly.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

The research showed that Vitamin D and its receptor are important for healthy bones and normal hair and skin in rats.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

A child with rickets and hair loss might have a rare type of rickets that doesn't improve much with usual vitamin D and calcium treatment.

Scientists improved an enzyme to better produce a hair growth-promoting chemical from an immunosuppressant.

Mutations in the POC1A gene can cause a unique form of extreme insulin resistance and short stature.

A new genetic mutation was found causing hair and eye issues in a boy.